Mark W. Reynolds
2021
In 2021, Mark W. Reynolds earned a total compensation of $478.3K as Chief Financial Officer at GeoVax Labs, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $94,000 |
|---|---|
| Option Awards | $138,334 |
| Salary | $234,392 |
| Other | $11,600 |
| Total | $478,326 |
Reynolds received $234.4K in salary, accounting for 49% of the total pay in 2021.
Reynolds also received $94K in bonus, $138.3K in option awards and $11.6K in other compensation.
Rankings
In 2021, Mark W. Reynolds' compensation ranked 10,810th out of 12,415 executives tracked by ExecPay. In other words, Reynolds earned more than 12.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,810 out of 12,415 | 13th |
Division Manufacturing | 4,765 out of 5,508 | 14th |
Major group Chemicals And Allied Products | 2,139 out of 2,378 | 10th |
Industry group Drugs | 1,901 out of 2,099 | 9th |
Industry Pharmaceutical Preparations | 1,407 out of 1,549 | 9th |
Source: SEC filing on June 12, 2023.
Reynolds' colleagues
We found two more compensation records of executives who worked with Mark W. Reynolds at GeoVax Labs in 2021.